Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

454

Participants

Timeline

Start Date

July 25, 2012

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2027

Conditions
Prostate Cancer
Interventions
RADIATION

Proton Beam Therapy

5 days per week up to 9 weeks

RADIATION

Intensity Modulated Radiation Therapy

5 times per week up to 9 weeks

Trial Locations (13)

19104

Hospital of the University of Pennsylvania, Philadelphia

20742

University of Maryland Medical Center, College Park

32206

University of Florida Health Proton Therapy Institute, Jacksonville

37909

Provision Proton Therapy Center, Knoxville

44106

University Hospital of Cleveland, Cleveland

55905

Mayo Clinic, Rochester

60190

Northwestern Medicine Chicago Proton Center, Chicago

63110

Washington University, St Louis

98195

University of Washington Medical Center, Seattle

02114

Massachusetts General Hospital, Boston

01923

Mass General/North Shore Cancer Center, Danvers

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

08873

Princeton ProCure Proton Therapy Center, Somerset

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

Northwestern Medicine Chicago Proton Center

UNKNOWN

collaborator

ProCure Proton Therapy Center

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

University of Washington

OTHER

collaborator

Rutgers Cancer Institute of New Jersey

OTHER

collaborator

Provision Center for Proton Therapy

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

University of Maryland, Baltimore

OTHER

collaborator

University Hospitals Cleveland Medical Center

OTHER

collaborator

University of Florida Proton Therapy Institute

UNKNOWN

lead

Massachusetts General Hospital

OTHER

NCT01617161 - Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer | Biotech Hunter | Biotech Hunter